Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
78.31+0.38 (+0.49%)
At close: 4:00PM EDT
78.35 +0.04 (+0.05%)
After hours: 04:17PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close77.93
Open77.86
Bid78.19 x 1100
Ask79.65 x 1000
Day's Range77.24 - 78.35
52 Week Range49.36 - 84.23
Volume204,335
Avg. Volume422,461
Market Cap7.816B
Beta (5Y Monthly)1.08
PE Ratio (TTM)43.53
EPS (TTM)1.80
Earnings DateNov 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est85.92
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GMED

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Globus Medical, Inc.
    GMED: Lowering target price to $80.00GLOBUS MEDICAL INC - A has an Investment Rating of HOLD; a target price of $80.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • GlobeNewswire

    Globus Medical Premieres ANTHEM® Mini Fragment Fracture System at Orthopaedic Trauma Association Meeting

    AUDUBON, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will feature its new ANTHEM® Mini Fragment Fracture System at the annual Orthopaedic Trauma Association (OTA) meeting in Fort Worth, Texas, Oct 20-23, 2021. The ANTHEM® Mini Fragment Fracture System is designed for fracture fixation of small bones and non-load-bearing stabilization of long bones in the upper and lower extremities. Implants are provided

  • GlobeNewswire

    Globus Medical Schedules Third Quarter Earnings Release and Conference Call

    AUDUBON, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2021 after the market close on Thursday, November 4, 2021. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at

  • SmarterAnalyst

    Globus Medical Files Patent Infringement Lawsuit Against Life Spine

    Medical devices firm Globus Medical, Inc. (GMED) has filed a patent infringement lawsuit against Illinois-based medical technology company Life Spine, Inc. In the lawsuit, Globus alleged that Life Spine has infringed on seven patents related to its expandable interbody spacer technology. Globus filed the lawsuit in the U.S. District Court for the District of Delaware and is seeking injunctive relief and damages from Life Spine. The lawsuit includes several products that Life Spine manufactures a

Advertisement
Advertisement